Skip to main content
Clinical Trials/NCT06860880
NCT06860880RecruitingNot Applicable

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

UNC Lineberger Comprehensive Cancer Center1 site in 1 country40 target enrollmentStarted: June 3, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
40
Locations
1
Primary Endpoint
The proportion of consented patients who are referred

Study Overview

Brief Summary

This health services study will assess a multidisciplinary intervention program directed at fatigue mitigation among patients diagnosed with indolent lymphomas. Specifically, 30 subjects with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and 10 subjects with Follicular Lymphoma (FL), marginal zone lymphoma (MZL), lymphoplasmacytic lymphoma (LPL), Waldenström's Macroglobulinemia, or Cutaneous T Cell Lymphoma (CTCL) will be included.

Detailed Description

All subjects will be assigned to an exercise and dietary intervention program. Patients will engage in two patient-clinician consultations for exercise and nutrition. The individualized exercise plan designed based on the subject's medical history, current exercise habits, and specific needs, will include a mix of aerobic and resistance training.

Concurrently, participants will receive nutritional consultations from a specialized oncology dietitian. These sessions will focus on creating a diet plan tailored to each participant's nutritional needs, considering their treatment and overall health. Study participants will complete weekly exercise journals to track adherence to the exercise prescription and complete weekly assessments of their adherence to dietary recommendations on an integer scale ranging from 0-10.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •In order to participate in this study a subject must meet all of the eligibility criteria outlined below.
  • •Inclusion Criteria:
  • •Written informed consent was obtained to participate in the study and HIPAA authorization for the release of personal health information.
  • •Subjects are willing and able to comply with study procedures based on the judgment of the investigator.
  • •Age ≥ 18 years at the time of consent.
  • •Confirmed diagnosis of indolent lymphoma, Waldenström's Macroglobulinemia, or Cutaneous T Cell Lymphoma.
  • •Significant symptoms of fatigue, as defined by PROMIS Fatigue score >50.

Exclusion Criteria

  • •Other co-existing malignancies.
  • •Significant cognitive impairment as defined by Mini-Cog score 0-2 (out of 5) that would prevent understanding of assessments or interventions.
  • •Unstable or serious illness (e.g., unstable cardiac arrhythmia, severe anemia/thrombocytopenia) that would prevent safe participation in an exercise regimen, per the discretion of the treating physician.
  • •Individuals who are not able to consume an oral diet, due to swallowing difficulties or other reasons, as this might interfere with the nutritional intervention

Arms & Interventions

Patients who are with chronic lymphocytic leukemia/small lymphocytic lymphoma

Other

Patients who are with chronic lymphocytic leukemia/small lymphocytic lymphoma were assessed and received exercise and diet programs.

Intervention: Exercise (Other)

Patients who are with chronic lymphocytic leukemia/small lymphocytic lymphoma

Other

Patients who are with chronic lymphocytic leukemia/small lymphocytic lymphoma were assessed and received exercise and diet programs.

Intervention: Diet (Other)

Outcomes

Primary Outcomes

The proportion of consented patients who are referred

Time Frame: Baseline

The proportion of consented patients with chronic lymphocytic leukemia (CLL) or other forms of indolent lymphoma who are referred to cancer rehabilitation and dietician and attend an initial appointment with each.

Secondary Outcomes

  • Overall acceptability(Baseline and post-3 months follow-up)
  • Differences in self-reported fatigue(Baseline and post-3 months follow-up)
  • Differences in overall health(Baseline and post-3 months follow-up)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials